Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-μg disks
- 30 June 1992
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (4) , 379-381
- https://doi.org/10.1016/0732-8893(92)90029-s
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628Diagnostic Microbiology and Infectious Disease, 1991
- In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391Diagnostic Microbiology and Infectious Disease, 1991
- Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesAntimicrobial Agents and Chemotherapy, 1991
- Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Comparative in vitro activity of a new quinolone, AM-1091Antimicrobial Agents and Chemotherapy, 1989
- Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivativeAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of PD 127,391, an enhanced-spectrum quinoloneAntimicrobial Agents and Chemotherapy, 1988